Alhambra Investment Partners LLC cut its position in AbbVie Inc. (NYSE:ABBV – Get Rating) by 23.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,780 shares of the company’s stock after selling 835 shares during the quarter. Alhambra Investment Partners LLC’s holdings in […]
Resolute Financial LLC lowered its stake in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 9.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,192 shares of the company’s stock after selling 454 shares during the quarter. Resolute Financial […]
PDS Planning Inc boosted its stake in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 9.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 121,752 shares of the company’s stock after purchasing an additional 10,600 shares during the period. AbbVie comprises about 3.5% […]
Columbia Trust Co 01012016 acquired a new stake in AbbVie Inc. (NYSE:ABBV – Get Rating) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 4,897 shares of the company’s stock, valued at approximately $795,000. A number of other hedge funds also […]
Wealthcare Advisory Partners LLC decreased its position in AbbVie Inc. (NYSE:ABBV – Get Rating) by 9.3% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 33,015 shares of the company’s stock after selling 3,401 shares during the quarter. Wealthcare Advisory Partners LLC’s holdings in AbbVie […]